BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2984332)

  • 1. Intravenous methylprednisolone for multiple sclerosis in relapse.
    Barnes MP; Bateman DE; Cleland PG; Dick DJ; Walls TJ; Newman PK; Saunders M; Tilley PJ
    J Neurol Neurosurg Psychiatry; 1985 Feb; 48(2):157-9. PubMed ID: 2984332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS.
    Thompson AJ; Kennard C; Swash M; Summers B; Yuill GM; Shepherd DI; Roche S; Perkin GD; Loizou LA; Ferner R
    Neurology; 1989 Jul; 39(7):969-71. PubMed ID: 2544829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom.
    Tremlett HL; Luscombe DK; Wiles CM
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):362-5. PubMed ID: 9728950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids and multiple sclerosis.
    Miller DH
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):290. PubMed ID: 9728938
    [No Abstract]   [Full Text] [Related]  

  • 5. "Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis.
    Abbruzzese G; Gandolfo C; Loeb C
    Ital J Neurol Sci; 1983 Jun; 4(2):169-72. PubMed ID: 6311774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Steroid therapy for multiple sclerosis].
    Oishi C; Sakuta M
    Nihon Rinsho; 2003 Aug; 61(8):1361-6. PubMed ID: 12962024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind randomized trial of ACTH versus dexamethasone versus methylprednisolone in multiple sclerosis bouts. Clinical, cerebrospinal fluid and neurophysiological results.
    Milanese C; La Mantia L; Salmaggi A; Campi A; Eoli M; Scaioli V; Nespolo A; Corridori F
    Eur Neurol; 1989; 29(1):10-4. PubMed ID: 2540005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.
    Milligan NM; Newcombe R; Compston DA
    J Neurol Neurosurg Psychiatry; 1987 May; 50(5):511-6. PubMed ID: 3295122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years].
    Sigwald J; Mazalton A; Raymondeaud C; Piot C; Jacquillat C
    Rev Neurol (Paris); 1973 Jan; 128(1):72-7. PubMed ID: 4367744
    [No Abstract]   [Full Text] [Related]  

  • 10. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.
    Filippini G; Brusaferri F; Sibley WA; Citterio A; Ciucci G; Midgard R; Candelise L
    Cochrane Database Syst Rev; 2000; (4):CD001331. PubMed ID: 11034713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral versus intravenous methylprednisolone for the treatment of multiple sclerosis relapses: A meta-analysis of randomized controlled trials.
    Liu S; Liu X; Chen S; Xiao Y; Zhuang W
    PLoS One; 2017; 12(11):e0188644. PubMed ID: 29176905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute improvement in exacerbating multiple sclerosis produced by intravenous administration of mannitol.
    Stefoski D; Davis FA; Schauf CL
    Ann Neurol; 1985 Oct; 18(4):443-50. PubMed ID: 3000278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylprednisolone in multiple sclerosis: a comparative dose study.
    Bindoff L; Lyons PR; Newman PK; Saunders M
    J Neurol Neurosurg Psychiatry; 1988 Aug; 51(8):1108-9. PubMed ID: 3063777
    [No Abstract]   [Full Text] [Related]  

  • 14. Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis.
    Dowling PC; Bosch VV; Cook SD
    Neurology; 1980 Jul; 30(7 Pt 2):33-6. PubMed ID: 6248819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Steroid therapy in multiple sclerosis].
    Beer S; Kesselring J
    Schweiz Med Wochenschr; 1991 Jun; 121(26):961-9. PubMed ID: 1650496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic indications for acute episodes of multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):988-95. PubMed ID: 11787365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of multiple sclerosis with Lyoproper].
    Aschoff JC; Conrad B
    Med Klin; 1971 Jun; 66(30):1055-8. PubMed ID: 4328079
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.
    Durelli L; Cocito D; Riccio A; Barile C; Bergamasco B; Baggio GF; Perla F; Delsedime M; Gusmaroli G; Bergamini L
    Neurology; 1986 Feb; 36(2):238-43. PubMed ID: 3511404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH].
    Wender M; Tokarz-Kupczyk E; Mularek O
    Neurol Neurochir Pol; 1988; 22(5):399-403. PubMed ID: 2854886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.
    Barnes D; Hughes RA; Morris RW; Wade-Jones O; Brown P; Britton T; Francis DA; Perkin GD; Rudge P; Swash M; Katifi H; Farmer S; Frankel J
    Lancet; 1997 Mar; 349(9056):902-6. PubMed ID: 9093250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.